CSL Behring today announced that the company has renewed its commitment as a Visionary Corporate Partner with the WFH for another three years. This is the fourth time the company has signed a multiyear commitment to support critical WFH programs that help improve diagnosis and access to care for patients in developing countries, provide medical training, increase awareness, establish education initiatives and achieve government support through advocacy.
“We are grateful for the collaboration with our corporate partners like CSL Behring,” said Alain Baumann, CEO of the World Federation of Hemophilia. “Their support enables us to fulfill our commitment to the bleeding disorders community by providing valuable education, advocacy and access to WFH programs to patients and healthcare professionals, and to provide quality scientific data to further advance the understanding and care of hemophilia.”
The agreement establishes CSL Behring as a “Leadership Partner” of the Global Alliance for Progress (GAP) Program that aims to increase the diagnosis and treatment of patients with hemophilia and other bleeding disorders in developing countries. CSL Behring will also participate as a “Collaborating Partner” of the World Bleeding Disorders Registry (WBDR), the world’s only global registry collecting standardized clinical data on hemophilia patients. In addition, CSL Behring will continue to be a significant contributor to the WFH Humanitarian Aid Program’s efforts to provide consistent and predictable treatment access through product donations and financial support.
To read the full press release, please click here.